Private Payer–Negotiated Prices for Outpatient Otolaryngologic Surgery

2021 ◽  
pp. 019459982110493
Author(s):  
Annette A. Wang ◽  
Roy Xiao ◽  
Rosh K.V. Sethi ◽  
Vinay K. Rathi ◽  
George A. Scangas

In January 2021, the Centers for Medicare & Medicaid Services began requiring hospitals to publish price transparency files listing all prices negotiated with payers. We performed a cross-sectional analysis of payer-negotiated prices for commonly performed outpatient otolaryngology surgery at all hospitals scored by the US News & World Report in otolaryngology. We compared prices among hospitals (across-center ratios) and among payers at the same hospital (within-center ratios). Price disclosure rates were low overall for otolaryngologic surgery (maximum, 26.7% for bronchoscopy). Across-center ratios ranged from 3.5 (adjacent tissue transfer/rearrangement <10 cm2; raw median price range, $1384-$7047) to 18.6 (cochlear implant placement; raw median price range, $2417-$60,255). Median within-center ratios ranged between 2.7 (intraoperative navigation) and 5.4 (total thyroidectomy). Although price variation may signal opportunities for cost savings, patients may have limited ability to comparison shop due to hospital nondisclosure. Further investigation is necessary to examine the factors affecting price variation for otolaryngologic procedures.

2020 ◽  
Vol 31 (S20) ◽  
pp. 174-174
Author(s):  
Ausra Ramanauskaite ◽  
Karina Obreja ◽  
Amira Begic ◽  
Puria Parvini ◽  
Frank Schwarz

2017 ◽  
Author(s):  
Justin D Triemstra ◽  
Rachel Stork Poeppelman ◽  
Vineet M Arora

BACKGROUND The US News and World Report reputation score correlates strongly with overall rank in adult and pediatric hospital rankings. Social media affects how information is disseminated to physicians and is used by hospitals as a marketing tool to recruit patients. It is unclear whether the reputation score for adult and children’s hospitals relates to social media presence. OBJECTIVE The objective of our study was to analyze the association between a hospital’s social media metrics and the US News 2017-2018 Best Hospital Rankings for adult and children’s hospitals. METHODS We conducted a cross-sectional analysis of the reputation score, total score, and social media metrics (Twitter, Facebook, and Instagram) of hospitals who received at least one subspecialty ranking in the 2017-2018 US News publicly available annual rankings. Regression analysis was employed to analyze the partial correlation coefficients between social media metrics and a hospital’s total points (ie, rank) and reputation score for both adult and children’s hospitals while controlling for the bed size and time on Twitter. RESULTS We observed significant correlations for children’s hospitals’ reputation score and total points with the number of Twitter followers (total points: r=.465, P<.001; reputation: r=.524, P<.001) and Facebook followers (total points: r=.392, P=.002; reputation: r=.518, P<.001). Significant correlations for the adult hospitals reputation score were found with the number of Twitter followers (r=.848, P<.001), number of tweets (r=.535, P<.001), Klout score (r=.242, P=.02), and Facebook followers (r=.743, P<.001). In addition, significant correlations for adult hospitals total points were found with Twitter followers (r=.548, P<.001), number of tweets (r=.358, P<.001), Klout score (r=.203, P=.05), Facebook followers (r=.500, P<.001), and Instagram followers (r=.692, P<.001). CONCLUSIONS A statistically significant correlation exists between multiple social media metrics and both a hospital’s reputation score and total points (ie, overall rank). This association may indicate that a hospital’s reputation may be influenced by its social media presence or that the reputation or rank of a hospital drives social media followers.


2019 ◽  
Author(s):  
Mollie McDermott ◽  
James F. Burke ◽  
Haley McCalpin ◽  
Anita V. Shelgikar ◽  
Douglas J. Gelb ◽  
...  

AbstractObjectiveTo determine whether speaking roles at five major neurology conferences in 2017 show disproportionate representation by men.MethodsThis study consisted of two cross-sectional analyses. In the first part, we compared speaker characteristics across meetings and by gender using descriptive statistics. In the second part, we linked presenters to the American Medical Association (AMA) Masterfile. For the primary analysis in the second part using linked AMA speaker data, we built models to estimate the influence of gender on speaker roles.Results1493 speakers were identified and included in our cross-sectional analysis. Women made up 28% of presenters from the US and 18% of presenters from other countries. After adjusting for years from medical school graduation and subspecialty, no effect of gender on speaker activity was observed (odds ratio [OR] for women 0.91; 95% confidence interval [CI], 0.77-1.07).ConclusionsFactors aside from national conference speaking activity should be investigated to better understand sex differences in rank at top-ranked academic neurology programs.


Nutrients ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 3426
Author(s):  
Pablo Alejandro Nava-Amante ◽  
Alejandra Betancourt-Núñez ◽  
Barbara Vizmanos ◽  
Miguel Amaury Salas-García ◽  
María Fernanda Bernal-Orozco ◽  
...  

Household food insecurity (FI) remains a major public health challenge worldwide. Data about perceived FI and its risk factors in Mexican university students are lacking. We aimed to assess FI’s prevalence and factors affecting it among university students’ households in Mexico. This cross-sectional analysis involved 7671 university students’ households using the 2018 Mexican National of Household Income and Expenditure Survey data. Variables analyzed included sociodemographic characteristics, and the 12-item validated Mexican Scale for Food Security (EMSA). Multivariable logistic regression modelling was performed to identify FI risk factors. The overall household FI prevalence was 30.8%. According to FI severity, prevalence rates were 16.3% for mild-FI, 8.8% for moderate-FI, and 5.7% for severe-FI. Low socioeconomic status (OR = 2.72; 95%CI: 2.09–3.54), low education level of household’s head (OR = 2.36; 95%CI: 1.90–2.94), self-ascription to an indigenous group (OR = 1.59; 95%CI: 1.41–1.79), attending public university (OR = 1.27; 95%CI: 1.13–1.43), female-headed household (OR = 1.26; 95%CI: 1.13–1.40), having worked recently (OR = 1.19; 95%CI: 1.07–1.33), and being in second year of studies (OR = 1.17; 95%CI: 1.03–1.33), were significantly related to FI. Our results confirm that FI is highly prevalent among Mexican university students’ households and that sociodemographic factors are essential in addressing this concern. Findings highlight the need for preventive programs and policies to alleviate FI.


2019 ◽  
Author(s):  
Jacqueline Nicholas ◽  
Batul Electricwala ◽  
Lulu K. Lee ◽  
Kristen M Johnson

Abstract Background: MS is prevalent among working age individuals (20-60 years), leading to high burden on work productivity. Few data are available about the absenteeism and presenteeism in employed individuals with MS in comparison to non-MS personnel. This study aimed to quantify the burden of illness of employed US adults with relapsing-remitting multiple sclerosis (RRMS) and examine burden by levels of work impairment. Methods: A retrospective cross-sectional analysis was conducted using patient-reported responses from the US National Health and Wellness Survey (NHWS). Data from NHWS 2015-2016 were analyzed from 196 employed RRMS respondents who were matched 1:4 to employed respondents without multiple sclerosis (MS) based on demographic and general health characteristics. Demographic and general health characteristics for employed RRMS individuals were analyzed by levels of work impairment (none, 1-30%; 31-68%; 69-100%). Work productivity (absenteeism, presenteeism, and work impairment), decrements in health-related quality of life (HRQoL) (short form-36, EQ-5D), and healthcare resource utilization (HCRU) were compared to determine the burden of RRMS. Results: After propensity score matching, the levels of absenteeism and presenteeism were 2 and 1.8 times higher in the employed RRMS population than the employed non-MS population, respectively (P<0.001 for both). HRQoL was significantly lower in employed respondents with RRMS than those without MS (P<0.001 for all). Employed respondents with RRMS had significantly more HCRU over 6 months compared to those without MS (P<0.001). Furthermore, among employed RRMS respondents, greater levels of impairment were associated with increasing disease severity, greater healthcare resource use, fatigue, and cognitive impairment and inversely associated with mental and physical HRQoL (P<0.0001 for all). Conclusions: Among employed individuals, respondents with RRMS had lower, work productivity, HRQoL, and higher HCRU as compared with those without MS. Given the large impact RRMS has on work impairment, a need exists to manage individuals on therapies that improve HRQoL, reduce symptoms, and improve their ability to perform in the workforce.


Urology ◽  
2020 ◽  
Vol 139 ◽  
pp. 97-103
Author(s):  
Clara Helene Glazer ◽  
Jake Anderson-Bialis ◽  
Deborah Anderson-Bialis ◽  
Michael L. Eisenberg

BMC Medicine ◽  
2019 ◽  
Vol 17 (1) ◽  
Author(s):  
Joshua D. Wallach ◽  
Anita T. Luxkaranayagam ◽  
Sanket S. Dhruva ◽  
Jennifer E. Miller ◽  
Joseph S. Ross

2017 ◽  
Vol 157 (4) ◽  
pp. 608-617 ◽  
Author(s):  
Vinay K. Rathi ◽  
Shekhar K. Gadkaree ◽  
Joseph S. Ross ◽  
Elliott D. Kozin ◽  
Rosh K. Sethi ◽  
...  

Objective The US Food and Drug Administration (FDA) clears moderate-risk devices via the 510(k) process based on substantial equivalence to previously cleared devices; evidence of safety and effectiveness is not required. We characterized the premarket evidence supporting FDA clearance of otolaryngologic devices. Study Design Retrospective cross-sectional analysis. Setting Publicly available FDA documents. Subjects and Methods Recently cleared (1997-2016) moderate-risk otolaryngologic devices were categorized by type (diagnostic/therapeutic), subspecialty, implantable designation (yes/no), and recall history (yes/no). Supporting evidence was categorized by type (clinical/nonclinical/none; nonclinical and clinical mutually inclusive) and public availability of nonclinical and clinical performance data (available/not provided/not applicable). Results Between 1997 and 2016, the FDA cleared 377 moderate-risk otolaryngologic devices. The majority were therapeutic (n = 240/377 [63.7%]) and otologic (n = 311/377 [82.5%]); roughly one-third (n = 121/377 [32.1%]) were implantable. Few (n = 10/377 [2.7%]) devices were subject to recall. FDA documents summarizing premarket evidence were accessible for two-thirds (n = 247/377 [65.5%]) of devices. Among these devices, one-quarter (n = 66/247 [26.7%]) were supported by clinical evidence. The majority (n = 177/247 [71.7%]) were supported by nonclinical evidence, although nearly one-quarter (n = 58/247 [23.5%]) were cleared without supporting evidence. Therapeutic devices were more often cleared without supporting evidence (therapeutic: n = 53/170 [31.2%]; diagnostic: n = 5/77 [6.5%]; P < .0001). Nonclinical and clinical performance data were rarely available (nonclinical: n = 49/247 [19.8%]; clinical: n = 32/247 [13.0%]) within public summaries. Conclusion The FDA cleared most moderate-risk otolaryngologic devices for marketing via the 510(k) process without clinical evidence of safety and effectiveness. Otolaryngologists should be aware of limitations in premarket evidence when considering the adoption of new devices into clinical practice.


Sign in / Sign up

Export Citation Format

Share Document